Rapid spectrophotometric determination and extraction of platinum(IV) from pharmaceuticals assisted by 2-(2-(1-(thiophene-2-yl) ethylidene) hydrazinyl) benzoic acid (TEHBA).

Abstract

It has been suggested that the chelating agent 2-(2-(1-thiophene-2-yl) ethylidene) hydrazinyl) benzoic acid (TEHBA) be utilized to extract, separate and measure platinum(IV) by UV-visible spectrophotometry at the microgram level. Following 5 min of heating the reaction mixture in a water bath, Pt(IV)-TEHBA complex formed. This complex was formed in the presence of potassium iodide solution with a molar absorption coefficient 1.9 × 103 dm3mol-1cm-1. At 420nm, the substance exhibited the greatest absorption. As Beer's law described, the Pt(IV)-TEHBA complex for platinum(IV) has a beer's range of 10-50μgcm-3. It was determined that the proportion ratio of the Pt(IV)-TEHBA complex was 1:1 after its extraction. Despite the investigation of interference from various ions, it was ascertained that the method exhibited selectivity exclusively towards platinum(IV). The trace amounts of platinum(IV) were extracted and quantified from synthetic mixtures representing alloys, binaries and ternary synthetic mixtures. The process of extracting platinum(IV) from pharmaceutical samples involves the implementation of a specific method. Moreover, the procedure exhibits a progressive segregation of palladium(II), platinum(IV) and nickel(II) while also boasting its ease of operation.